Survival In Advanced Gist Has Improved Over Time And Correlates With Increased Access To Post-Imatinib Tyrosine Kinase Inhibitors: Results From Life Raft Group Registry (Vol 9, 4, 2019)

CLINICAL SARCOMA RESEARCH(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要